Spots Global Cancer Trial Database for nelfinavir
Every month we try and update this database with for nelfinavir cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma | NCT00694837 | Glioblastoma | nelfinavir | 18 Years - 65 Years | Maastricht Radiation Oncology | |
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery | NCT04169763 | Stage II Vulvar... Stage III Vulva... Stage IIIA Vulv... Stage IIIB Vulv... Stage IIIC Vulv... Stage IVA Vulva... | Cisplatin External Beam R... Nelfinavir | 18 Years - | M.D. Anderson Cancer Center | |
A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia | NCT01925378 | Cervical Dyspla... | Nelfinavir | 18 Years - | The University of Texas Health Science Center, Houston | |
Nelfinavir, a Phase I/Phase II Rectal Cancer Study | NCT00704600 | Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | nelfinavir | 18 Years - | Maastricht Radiation Oncology | |
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma | NCT01020292 | Glioma | Nelfinavir | 18 Years - | Abramson Cancer Center at Penn Medicine | |
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery | NCT04169763 | Stage II Vulvar... Stage III Vulva... Stage IIIA Vulv... Stage IIIB Vulv... Stage IIIC Vulv... Stage IVA Vulva... | Cisplatin External Beam R... Nelfinavir | 18 Years - | M.D. Anderson Cancer Center | |
Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma | NCT02188537 | Myeloma | Nelfinavir bortezomib Dexamethasone | 18 Years - | Swiss Group for Clinical Cancer Research | |
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer | NCT00791336 | Carcinoma, Non-... | Nelfinavir | 18 Years - | University of Iowa | |
Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma | NCT01555281 | Multiple Myelom... | Nelfinavir Lenalidomide Dexamethasone | 18 Years - | Swiss Group for Clinical Cancer Research | |
Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 | NCT02024009 | Pancreatic Neop... | nab-paclitaxel 60Gy in 30# 50.4Gy in 28# Nelfinavir Capecitabine Gemcitabine | 18 Years - | University of Oxford | |
Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck | NCT01065844 | Carcinoma, Aden... Head and Neck N... | Nelfinavir | 18 Years - | University of Iowa | |
A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA) | NCT02363829 | Uterine Cervix ... | Nelfinavir Cisplatin | 18 Years - | Abramson Cancer Center at Penn Medicine | |
Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck | NCT01065844 | Carcinoma, Aden... Head and Neck N... | Nelfinavir | 18 Years - | University of Iowa | |
Radical Lung Radiotherapy Plus Nelfinavir | NCT01447589 | Lung Cancer | nelfinavir Radical Radioth... | 18 Years - | Oxford University Hospitals NHS Trust | |
Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery | NCT04169763 | Stage II Vulvar... Stage III Vulva... Stage IIIA Vulv... Stage IIIB Vulv... Stage IIIC Vulv... Stage IVA Vulva... | Cisplatin External Beam R... Nelfinavir | 18 Years - | M.D. Anderson Cancer Center | |
A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 | NCT00002185 | Sarcoma, Kaposi HIV Infections | Nelfinavir mesy... | 13 Years - | NIH AIDS Clinical Trials Information Service | |
Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC) | NCT01108666 | Non Small Cell ... | Nelfinavir | 18 Years - | Abramson Cancer Center at Penn Medicine | |
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer | NCT00791336 | Carcinoma, Non-... | Nelfinavir | 18 Years - | University of Iowa | |
Radical Lung Radiotherapy Plus Nelfinavir | NCT01447589 | Lung Cancer | nelfinavir Radical Radioth... | 18 Years - | Oxford University Hospitals NHS Trust | |
A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA) | NCT02363829 | Uterine Cervix ... | Nelfinavir Cisplatin | 18 Years - | Abramson Cancer Center at Penn Medicine | |
Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer | NCT01086332 | Pancreatic Neop... | Nelfinavir Gemcitabine | 18 Years - | University of Iowa | |
Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma | NCT01555281 | Multiple Myelom... | Nelfinavir Lenalidomide Dexamethasone | 18 Years - | Swiss Group for Clinical Cancer Research | |
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma | NCT01020292 | Glioma | Nelfinavir | 18 Years - | Abramson Cancer Center at Penn Medicine | |
Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma | NCT03422874 | Neoplasms Lymphoma | MLN9708 Nelfinavir | 18 Years - | Dartmouth-Hitchcock Medical Center |